Drug Class
IDH2 inhibitor
Type
brand
Active Ingredient
enasidenib
📋Overview
Idhifa is a medication that targets specific genetic mutations found in certain types of cancer cells. It is most commonly associated with the treatment of acute myeloid leukemia (AML) in adults who have a particular mutation in the IDH2 gene. By inhibiting the abnormal enzyme produced by this mutation, Idhifa helps to slow the growth of cancerous cells. This drug is part of a class of targeted therapies used in oncology.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Idhifa
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.